GSK

Showing 15 posts of 760 posts found.

GSK image

GSK admits: Execs ‘breached Chinese law’

July 22, 2013
Medical Communications, Sales and Marketing China, GSK, bribes, scandal

A senior GlaxoSmithKline executive has admitted that some of the firm’s staff have broken the law in China as a …

Liang Hong image

GSK finance director barred from leaving China

July 18, 2013
Medical Communications, Sales and Marketing GSK, bribes, corruption, hong

GlaxoSmithKline’s finance director and British citizen Steve Nechelput has been stopped from the leaving China as the bribery case into …

GSK image

GSK exec admits bribery on live TV

July 16, 2013
Medical Communications, Sales and Marketing China, GSK, bribery, cctv

A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …

GSK image

China accuses GSK of large scale bribery

July 12, 2013
Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat

Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …

GSK image

GSK files cancer combination

July 10, 2013
Sales and Marketing FDA, GSK, Tafinlar, mekinist

GlaxoSmithKline has put in supplemental applications for its Tafinlar/Mekinist combination – a pair of drugs which analysts predict may have …

GSK image

GSK teams up with Oxford biotech on cancer

July 9, 2013
Research and Development, Sales and Marketing GSK, Oxford, immunocore

GlaxoSmithKline has announced a partnership with a UK biotech firm to develop oncology medicines using new methods to fight the …

GSK image

GSK China probe extends to Botox sales

July 8, 2013
Sales and Marketing Botox, China, GSK, whistleblower

GlaxoSmithKline’s woes in China are continuing as the firm’s sales tactics with Botox are put under scrutiny. The London-based firm …

GSK image

GSK under investigation in China

July 4, 2013
Sales and Marketing China, GSK, NDRC, corruption

GlaxoSmithKline is being investigated by authorities in China in what appear to be two separate probes into the UK manufacturer’s …

Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

GSK image

GSK mulling sales of thrombosis brands and facility to Aspen

June 24, 2013
Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen

GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …

GSK image

GSK receives thrombosis offer

June 19, 2013
Sales and Marketing GSK, aspen, thrombosis

GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …

GSK image

GSK fires head of China research over data fraud

June 11, 2013
Research and Development China, GSK, Jingwu Zang, MS, autoimmune

GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …

GSK image

GSK licences RA drug

June 5, 2013
Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …

GSK image

FDA approves GSK cancer drugs

May 30, 2013
Sales and Marketing FDA, GSK

The FDA has approved two of GlaxoSmithKline’s cancer pills: BRAF-inhibitor Tafinlar and the first validated MEK-inhibitor, called Mekinist, both of …

The Gateway to Local Adoption Series

Latest content